Komathi Stem

Komathi Stem is a seasoned professional with extensive experience in the healthcare and biotechnology sectors. Currently serving as a Strategic Advisor at Oncoustics since June 2021, Komathi provides strategic guidance for the development of AI/ML solutions in point-of-care diagnostics. As the Chief Executive Officer of ReThynk Consulting since February 2016, and a Board Member at CoPeace since September 2018, Komathi's leadership spans across various organizations. Previous roles include Chief Operating Officer at Glooko and Founder and CEO of monARC Bionetworks, Inc., focusing on democratizing research and accelerating drug discovery. Notable experience at Genentech involved positions such as Strategic Innovation Consultant and Senior Director of Product Development, along with leadership roles at Science 37, Inc., AstraZeneca, and Eli Lilly and Company. Komathi holds a Master's degree in Biomedical/Medical Engineering and a Bachelor's degree in Mathematics from the University of Virginia and St. Olaf College, respectively.